genae, a global service provider for the medical industries, today announced the launch of staicy, a data-driven health and research management platform.
genae announced today the appointment of Thomas De Kempeneer as a member of genae’s board of directors.
genae, a global Contract Research Organization (CRO) and service provider for the medical industries, announced the closing of an investment in Meditrix. The clinical research group further obtained a call option to acquire all remaining shares of Meditrix.
The FIRE AND ICE trial is a multicenter, randomized, noninferiority, parallel-group, open-label trial, with blinded end-point assessment, in which cryoballoon ablation was compared with radiofrequency ablation.